Helin Group

The main goal of our research is to contribute to the understanding of the molecular mechanisms leading to cancer and to identify proteins that are required for cancer maintenance as potential new targets for therapy.

































































































































Program for translational hematology (PTH)

PTH is a translational research program aiming at improving immediate and long-term clinical outcome for hematological patients. Through interdisciplinary basic and clinical research, we work together to uncover mechanisms leading to hematopoietic malignancies, identify new potential drug targets, and to improve the treatments for these malignancies.

Read more about PTH